Hunter Prostate Cancer Alliance

Hunter Prostate Cancer Alliance is challenged to provide primary care support for men, their partners, families and colleagues when they seek information and services relating to a diagnosis of prostate cancer.

We also work to encourage men over 40 years of age to take advantage of the simple "Little Prick" test know as a PSA test. This test is performed by your GP and looks for Prostate Specific Antigen which can be the first indicator that something is wrong with the prostate.

Early diagnosis of prostate cancer increases the likelihood of a full cure.

The Alliance is firstly targeting men over 40 years of age as the chance of developing prostate cancer for such a man is 1 in 8 throughout his remaining life. Also, men with a family history of prostate cancer as they have a risk of at least three times greater, than those who do not have such a family history, and should be tested from the age of 40.

HPCA Purpose

To assist individuals and groups of men and women with information about prostate cancer, in order to promote rational testing of men for this disease and to encourage the development of intellectual and emotional support systems for men diagnosed with prostate cancer and those supporting them.

HPCA Mission

Advocate a strong awareness within the Hunter New England region of the need for immediate initial testing and thereafter regular prostate cancer testing as frequently as available evidence dictates in order to curb this disease in its onset.
Provide primary care services to newly diagnosed men, their partners, families and colleagues to understand and come to terms with the complexity of this disease along with the variety of options available for treatment.
Encourage the development of services that will promote a positive mental outlook for those affected by this disease and in those supporting them.
Emphasise the importance of continued education to recognise and deal with the many far reaching effects of prostate cancer, including the fact that many low grade cancers may be safely monitored without treatment.